Regulation of immune responses by E3 ubiquitin ligase Cbl-b
被引:69
作者:
Tang, Rong
论文数: 0引用数: 0
h-index: 0
机构:
Cent South Univ, Dept Nephrol, Xiangya Hosp, Changsha, Hunan, Peoples R ChinaCent South Univ, Dept Nephrol, Xiangya Hosp, Changsha, Hunan, Peoples R China
Tang, Rong
[1
]
Langdon, Wallace Y.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Western Australia, Sch Biol Sci, Perth, WA, AustraliaCent South Univ, Dept Nephrol, Xiangya Hosp, Changsha, Hunan, Peoples R China
Langdon, Wallace Y.
[2
]
Zhang, Jian
论文数: 0引用数: 0
h-index: 0
机构:
Univ Iowa, Dept Pathol, Iowa City, IA 52242 USACent South Univ, Dept Nephrol, Xiangya Hosp, Changsha, Hunan, Peoples R China
Zhang, Jian
[3
]
机构:
[1] Cent South Univ, Dept Nephrol, Xiangya Hosp, Changsha, Hunan, Peoples R China
[2] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia
[3] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA
Casitas B lymphoma-b (Cbl-b), a RING finger E3 ubiquitin ligase, has been identified as a critical regulator of adaptive immune responses. Cbl-b is essential for establishing the threshold for T cell activation and regulating peripheral T cell tolerance through various mechanisms. Intriguingly, recent studies indicate that Cbl-b also modulates innate immune responses, and plays a key role in host defense to pathogens and anti-tumor immunity. These studies suggest that targeting Cbl-b may represent a potential therapeutic strategy for the management of human immune-related disorders such as autoimmune diseases, infections, tumors, and allergic airway inflammation. In this review, we summarize the latest developments regarding the roles of Cbl-b in innate and adaptive immunity, and immune-mediated diseases.
引用
收藏
页数:9
相关论文
共 103 条
[1]
Acharya D, 2017, J VIROL, V91, DOI [10.1128/JVI.01529-16, 10.1128/jvi.01529-16]